Home blood tests for phenylketonuria management
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at whether checking phenylalanine levels at home more often helps people with classic PKU keep their levels in a healthy range. It may help you manage your diet and treatment more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have classic phenylketonuria (PKU) and follow a low-protein diet with special amino acid supplements.
- Your recent phenylalanine levels (from your last 3 tests) are between 360 and 900 μmol/L.
- You have been following a phenylalanine-restricted diet for at least 6 months and are willing to continue.
- You are not pregnant or planning pregnancy, and you are not using certain PKU medications (like sapropterin or pegvaliase).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new home blood test (Egoo Phe) for measuring phenylalanine levels in people with PKU, as well as in healthy adults. It aims to see if it is accurate and easy to use.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) cope with daily life, emotions, and relationships, with input from a relative who lives with them. The goal is to better understand the challenges so care can be improved.
This study tests a new one-time gene therapy injection (called GS1168) for adults with phenylketonuria (PKU). It aims to help your body break down the amino acid phenylalanine better, so your diet may become less strict.
This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.
This study is testing whether a new microtablet form of protein substitute is easy and acceptable for people with PKU to take. If you qualify, you'll take these tablets instead of your current protein substitute and share your experience with the research team.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
Hear when a new Phenylketonuria (PKU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.